S. 6 · 117th Congress
Biosimilar Red Tape Elimination Act
- Stage
- In committee
- Sponsor
- Mike Lee
- Introduced
- 2022-11-17
- Latest action
- 2022-11-17 · Introduced in Senate
Summary
Biosimilar Red Tape Elimination Act
This bill removes and otherwise modifies certain requirements related to the approval of biosimilars, such as prohibiting the Food and Drug Administration from requiring studies that assess the risks of switching between the biosimilar and the reference biologic.